Tokyo, Oct. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063198) titled 'Evaluation of the Safety of Remimazolam in Patients Receiving Long-Term Benzodiazepine Therapy' on Oct. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Red Cross Medical Center
Condition:
Condition - Surgical patients receiving long-term benzodiazepine therapy who are scheduled for general anesthesia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In patients receiving long-term benzodiazepine therapy, tolerance may lead to an unpredictable anesthetic response to remimazolam, potentially resulting in increased dose requirements and delayed emerge...